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1. Introduction
  Diabetes mellitus is a chronic incurable condition 
due to insulin deficiency that affects large proportion 
of the world population. The number of diabetic people 
is expected to rise from present estimate of 150 million 
to 230 million in 2025[1]. Several attempts were made to 
reduce the hyperglycemia in diabetes such as treatment 
by sulfonylureas, which stimulates pancreatic islet cells to 
secrete insulin; metformin, which acts to reduce hepatic 
glucose production; 毩-glucosidase inhibitors, which 
interfere with glucose adsorption and insulin itself, which 
suppresses glucose production and augments glucose 
utilization[2]. These therapies have limited efficacy and 
side effects, and thus searching for new classes of drugs 
is essential to overcome the problems posed by diabetes. 
Nowadays, many indigenous medicinal plants have been 
found to be useful in managing diabetes and the search is 
unlimited[3-5]. 
  African mistletoes (Viscum album (V. album)) (family 
Loranthaceae), are well known as hemi-parasites of 
different gymnosperms and angiosperms. They are of great 
Objective: To justify the use of African mistletoe (AM) Viscum album (V. album) in folkoric 
medicine to treat diabetes. Methods: In one experiment, the fasting blood glucose (FBG) levels of 
diabetic rats were monitored for 4 h. Diabetic rats were treated with AM at doses of 50 mg/kg (AM1) 
and 100 mg/kg (AM2), glibenclamide (GB) (positive control) and saline solution (SS). In another 
experiment, diabetic rats were treated with AM2, GB and SS daily for 3 weeks. Results: AM1 
and AM2 elicited significant (P<0.05) hypoglycaemic effects within 4 h of extract administration. 
AM1 and AM2 decreased the FBG by 41% and 49%, respectively, at 2 h. AM2 was found to lower 
FBG by 51%, relative to baseline, which was comparable to GB at 3 h. In the second experiment, 
AM2 and GB significantly (P<0.05) decreased the FBG by 34% and 51%, respectively. This was 
followed by marked decrease in levels of HbA1C in AM2- and GB- treated diabetic rats. AM2 
significantly (P<0.05) decreased the STZ-induced increase in levels of serum triglyceride, urea, 
lactate dehydrogenase, 毩-amylase and low-density lipoprotein-cholesterol. Furthermore, 
diabetic rats treated with AM2 had significantly (P<0.05) elevated high-density lipoprotein-
cholesterol. In contrast, STZ administration produced insignificant (P<0.05) effect on the levels of 
serum creatinine and total bilirubin. Conclusions: Extract of African mistletoe has anti-diabetic 
and anti-hyperlipidemic effects in STZ-diabetic rats. AM may find clinical application in the 
amelioration of diabetes-induced lipid disorders.
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economic importance because of the major damages they 
cause to their host which results to economic losses[6]. 
Mistletoes have been used in the treatment and management 
of many diseases in traditional medicine in Africa. It has 
been reported to be effective in the management of chronic 
metabolic disorders[7]. A number of biological effects, 
such as anticancer, anti-microbial, apoptosis-inducing 
and immune-modulatory activities have been reported 
for mistletoes[8]. Mistletoe teas and infusions are used for 
prevention and management of stroke in Nigeria, and it is 
used to improve the circulatory system and heart function[5].
However, there is dearth of scientific data to justify and 
support the use of this plant in folkloric medicine. This 
study was undertaken to investigate the effect of African 
mistletoe on carbohydrate metabolism and lipids profile of 
streptozotocin-induced diabetic rats.
2. Materials and methods 
2.1. Chemicals 
  Streptozotocin was purchased from Sigma Chemical Co., 
Saint Louis, MO USA. Serum biochemical analysis was done 
by automated system at the Tehran University Teaching 
Hospital, Iran. Other chemicals were of analytical grade and 
the purest quality available.
2.2. Plant material and extraction procedure
  Samples of fresh African mistletoe (Parasitic on Kola 
acuminate tree) were obtained from forest at Oke-Ogun 
area of Oyo State, Nigeria. The botanical identification and 
authentication was confirmed at the herbarium of Forestry 
Research Institute of Nigeria (FRIN), Ibadan, where voucher 
specimen (FHI 108411) was kept. The plant was air-dried 
at room temperature and then powdered. The powdered 
samples (1 kg) were de-fatted with n-hexane (2 500 mL) and 
extracted with methanol (2 500 mL) overnight in a soxhlet 
extractor. The crude methanolic extract was concentrated 
and evaporated to dryness with a rotary evaporator under 
reduced pressure. The yield of the crude extract was 6.4%. 
2.3. Animals
  Male Wistar rats, 220-230 g, were used for the study. The 
rats were 10-12 weeks of age at the time of this study. They 
were bred and housed in the Central Animal House, Faculty 
of Pharmacy, Tehran University of Medical Sciences, Iran. 
The animal house was well ventilated with a 12 h light-dark 
cycle. They were fed on normal laboratory chow and allowed 
free access to water for two weeks before the commencement 
and during the period of the experiment. Handling of 
animals and other protocols conform to the guidelines of the 
National Institutes of Health (NIH publication 85-23, 1985). 
The study was approved by the Animal Ethical committee of 
University of Tehran, Iran.
2.4. Study design
2.4.1. Experiment 1
  The effect of extract of African mistletoe (AM) on FBG 
levels of STZ-diabetic rats was studied within 4 h of extract 
administration. The procedure described by Sharma et al[9] 
was adopted in this study. Rats were fasted overnight and 
made hyperglycemic by a single intraperitoneal injection of 
STZ dissolved in 0.05 M of citrate buffer (pH 4.3), at a dose of 
35 mg/kg[10]. The FBG of these rats were estimated 72 h after 
STZ administration, and moderately diabetic rats having 
FBG level above 250 mg/dL were selected and divided 
into four groups of 6 animals each. One group served as 
negative control (received vehicle), two groups were given 
AM at doses of 50 and 100 mg/kg (AM1 and AM2) and the 
last group received glibenclamide (GB) (positive control) at 
a dose of 5 mg/kg. A group of non-diabetic rats was also 
included during this study. The FBG per rat in all groups 
were estimated just before a single dose of GB or AM was 
administered and, the FBG monitored at 30, 60 and 90-240 
min after drugs administration.
2.4.2. Experiment 2
  The effect of extract of African mistletoe administered daily 
for 3 consecutive weeks was studied in STZ-diabetic rats. 
Another set of STZ-diabetic rats were randomly divided 
into three groups of 6 rats each. One group received saline 
solution (vehicle) (STZ only). The second and third groups 
received African mistletoe at 100 mg/kg (STZ+AM2), and 
glibenclamide at 5 mg/kg (STZ+GB), respectively, daily for 
3 consecutive weeks. The fourth group consists of non-
diabetic rats (Normal). After the last dose of the drugs, 
rats were fasted overnight and sacrificed by cervical 
dislocation. Visceral organs were obtained by dissection and 
immediately weighed, while blood was collected from the 
heart of the animals into plain centrifuge tubes
2.5. Preparation of serum
  Blood samples were allowed to stand for 1 h and then 
centrifuged at 3 000 g for 15 min in an MSC bench centrifuge 
to obtain serum. The clear supernatant (serum) was used for 
the estimation of urea, creatinine, enzymes, lipid profile and 
other parameters.   
2.6. Biochemical assays 
  Glucose levels were determined by the glucose oxidase 
method of Sharma et al[9]. The protein contents in the 
samples were assayed by the method of Lowry et al[11] 
using bovine serum albumin as standard. Serum urea and 
creatinine levels were determined by the method of Talke 
and Schubert[12] and Jaffe[13], respectively. The activities 
of alanine and aspartate aminotransferases (ALT and AST) 
were assayed by the combined methods of Mohun and 
Cook[14] and, Reitman and Frankel[15]. Serum 毭-glutamyl 
transferase (GGT) activity was assayed by the method of 
Fossati et al[16]. The activities of 毩-amylase and lactate 
dehydrogenase (LDH) were determined by the methods 
of Gella et al[17] and, Zimmerman and Weinstein[18], 
respectively. The levels of HbA1c were determined by the 
enzymatic method of Hirokawa et al[19]. The estimation of 
alkaline phosphatase (ALP) activity was based on the method 
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of Williamson[20]. Total bilirubin level was assayed by the 
method of Rutkowski and Debaare[21]. Serum triglyceride 
and cholesterol levels were assayed using commercial 
diagnostic kits (Randox). For the determination of HDL level, 
VLDL and LDL lipoproteins were precipitated by addition 
of phosphotungstic acid and magnesium chloride. After 
centrifugation, the supernatant containing the HDL fraction 
was assayed for cholesterol using Randox diagnostic kit. 
LDL–cholesterol (LDL-C) was calculated using the formula 
of Friedewald et al[22].
2.7. Statistical analysis
  All values were expressed as the mean ± S.D. of six animals 
per group. Data were analyzed using one-way ANOVA 
followed by the post-hoc Duncan multiple range test for 
analysis of biochemical data using SPSS (10.0). Values were 
considered statistically significant at P<0.05.
3. Results 
3.1. Phytochemical analysis of crude methanolic extract of 
African mistletoe (AM) 
  The phytochemical screening of crude methanolic extract 
of AM revealed the presence of bioactive compounds in 
the plant. Seven bioactive constituents were tested, out of 
which two tested positive. Analysis of tannins and flavonoids 
were positive while alkaloids, phlobatannins, saponins, 
anthraquinones and cardiac glycosides were completely 
absent in the extract.  
3.2. Effect of extract of African mistletoe administered at 50 mg/kg
(AM1) and 100 mg/kg (AM2) on blood glucose levels of 
STZ-diabetic rats within 4 h of administration
  In STZ-diabetic rats, AM1 was found to decrease FBG by 
41%, 42% and 41%, while AM2 decreased FBG by 49%, 51% 
and 50%, after 120, 180 and 240 min of extract administration, 
respectively. Similarly, glibenclamide (GB) progressively 
lowered the FBG of the rats by 50%, 51% and 49%, at 120, 
180 and 240 min after GB administration. Importantly, the 
hypoglycemic effects of GB were statistically similar to AM2 
at 180 and 240 min after administration. In addition, the FBG 
levels in diabetic rats that received saline solution, that is 
negative control (STZ only) remain statistically unchanged 
(P>0.05) during the study (Table 1).
3.3. The effect of AM2 on body weight and FBG of STZ-
diabetic rats
  Table 2 shows the effect of AM2 on body weight and relative 
weight of organs of STZ-diabetic rats. The final body weight 
of STZ-diabetic rats decreased significantly (P>0.05) when 
compared with normal. Also, the change in body weight was 
highest for untreated STZ-diabetic rats when compared with 
GB- and extract- diabetic rats. Similarly, the relative weight 
of liver in untreated STZ group was significantly (P>0.05) 
higher than others. At the end of this study, the FBG levels 
of STZ-diabetic animals treated with AM2 and GB decreased 
significantly (P>0.05) when compared with untreated diabetic 
group (Figure 1). In addition, both AM2 and GB significantly 
(P>0.05) decreased the HbA1c levels of the treated diabetic 
rats when compared to untreated diabetic group (Table 3).
Table 1
Effect of extract from African mistletoe on the level of fasting blood glucose in streptozotocin-diabetic rats.
Time (min)
Fasting blood glucose (mg/dL)
Normal (non-diabetic) STZ only STZ+AMI STZ+AM2 STZ+GB
    0 68.5依4.3 368.2依34.6 385.1依32.3 383.2依35.5 369.0依27.4
  30 65.3依6.1 360.7依28.6 353.6依39.8 361.3依37.2 375.1依37.7
  60 66.3依3.8 365.3依31.8 332.0依41.0 311.2依26.7  228.5依27.3
*
  90 68.1依5.4 361.2依41.0  227.2依18.5
*
 214.1依19.3
*
 189.3依19.0
*
120 67.5依7.3 370.0依39.6  225.1依21.6
*
 196.7依15.3
*
 183.3依21.6
*
180 69.2依6.8 368.5依37.2  223.7依24.1
*
 187.4依16.9
*
 185.6依18.0
*
240 68.0依5.2 364.8依35.1  228.0依18.4
*
 190.5依21.8
*
 187.9依17.5
*
Values are means依S.D. of 5 rats per group. *Significantly differeent from normal at P<0.05. STZ=Streptozotocin, AMI=African mistletoe at a 
dose of 50 mg/kg, AM2=African mistletoe at a of 100 mg/kg, GB=Glibenclamide.
Table 2
Effect of extract from African mistletoe on the body weight and relative weight of organs of streptozotocin-diabetic rats.
Treatment
body weight (g) Weight (g) Relative weight (% body weight)
Initial Final Change Liver Kidney Heart Liver Kidney Heart
Normal 225.1依5.3 241.3依6.2 16.2依5.6 6.8依0.5 1.3依0.1 0.8依0.1 2.8依0.3 0.50依0.09 0.30依0.05
STZ only 226.3依4.7 178.0依9.1
*
-48.3依8.3 7.1依0.8 1.2依0.2 0.8依0.1 4.0依0.5
*
0.60依0.07 0.40依0.05
STZ+AM2 231.6依6.2 208.5依7.4 -23.1依6.0 7.0依0.5 1.3依0.1 0.9依0.2 3.4依0.5 0.60依0.10 0.40依0.05
STZ+GB 228.4依4.4 204.6依8.0 -23.8依7.3 7.2依0.8 0.3依0.2 0.8依0.1 3.5依0.4 0.60依0.08 0.40依0.08
Values are means依S.D. of 6 rats per group. * Significantly different from normal at P<0.05. STZ=Streptozotocin, AM2= African mistletoe at 100 
mg/kg, GB=Glibenclamide.
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Figure 1. Effect of extract from African mistletoe on the levels of 
fasting glucose of streptozotocin (STZ)-diabetic rats.
  
3.4. Effects of AM2 on the lipid profiles of STZ-diabetic rats
  STZ-intoxication caused a significant increase (P>0.05) in 
the serum total cholesterol and triglycerides of untreated 
diabetic animals when compared with normal (Figure 2). 
Precisely total cholesterol and triglycerides were increased 
by 56% and 65%, respectively in untreated diabetic rats. 
Furthermore, serum LDL-cholesterol level of untreated STZ-
diabetic rats increased by 75% relative to normal (Figure 4). 
In contrast, untreated STZ-diabetic rats had significantly 
(P>0.05) lowered serum HDL-cholesterol level when 
compared with normal (Figure 2). Administration of AM2 
significantly reduced (P>0.05) the hypercholesterolemia and 
hypertriglyceridemia in these diabetic rats (Figures 2 and 4). 
Also, AM2 significantly (P>0.05) reversed the adverse effect 
of STZ on HDL-cholesterol levels in the animals (Figure 2).
The reversal effect of AM2 on the lipid profile of STZ-
diabetic rats was much stronger than GB-treated diabetic 
rats.
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Figure 2. Effect of extract from African mistletoe on the levels of 
serum cholesterol, triglyceride and HDL-cholesterol of streptozotocin 
(STZ)-diabetic rats.
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Figure 3. Effect of extract from African mistletoe on the levels of 
serum creatinine and total bilirubin of streptozotocin (STZ)-diabetic 
rats.
Table 3
Effect of extract from African mistletoe on some biochemical indices in streptozotocin-diabetic rats.
Treatment
Serum
Red cell HbA1c (%)
Protein (mg/dL) LDH (IU/L)
Normal 1.82依0.46   579.8依31.2 4.20依0.28
STZ only 1.63依0.38 1 137.0依51.3
*
  8.30依0.36
*
STZ+AM2 1.74依0.35     728.4依39.7
** 
   6.10依0.41
**
STZ+GB 1.86依0.44     824.2依43.2
**
   6.20依0.22
**
Values are means依S.D. of 6 rats per group. * Significantly different from normal at P<0.05. ** Singnificantly different from STZ only at 
P<0.05. STZ=Streptozotocin, AM2=African mistletoe at 100 mg/kg, GB=Glibenclamide, HbA1c=Glycosylated hemoglobin, LDH= Lactate 
dehydrogenase.
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Figure 4. Effect of extract from African mistletoe on the levels of 
serum urea, gamma glutamyl transferase and LDL-cholesterol of 
streptozotocin (STZ)-diabetic rats.
3.5. Effects of AM2 on the kidney and liver function indices of 
STZ-diabetic rats
  Figures 3-6 and Table 3 show that the STZ intoxication 
produced insignificant (P>0.05) effect on the levels of serum 
total bilirubin, creatinine, gamma glutamyl transferase, 
alanine and aspartate aminotransferases and alkaline 
phosphatase in the rats when compared with normal. 
In contrast, STZ-diabetic rats had significantly (P>0.05) 
increased levels of serum urea, lactate dehydrogenase (LDH) 
and 毩-amylase relative to normal. Treatment with AM2 
significantly (P>0.05) ameliorated the STZ-induced elevation 
in these biochemical indices. 
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Figure 5. Effect of extract from African mistletoe on the activities 
of serum alanine and aspartate aminotransferases (ALT and AST) of 
streptozotocin (STZ)-diabetic rats.
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Figure 6. Effect of extract from African mistletoe on the activities of 
serum alkaline phosphatase and 毩-amylase of streptozotocin (STZ) 
diabetic rat.
4. Discussion 
  Research conducted over decades, and the on-going 
studies have shown that plants and plant- based therapies 
may be potent means of controlling and treating diabetes and 
its complications[23-25]. Appropriate nutritional management 
is essential for restoring and maintaining a normal metabolic 
state. Therefore, diet remains a cornerstone in diabetic 
management. Spices and cereals such as Fenugreek, curry 
patta (Murraya koenigii), Brassica juncea, commonly used 
as dietary constituents have been found to have beneficial 
effect on carbohydrate metabolism experimentally, as well 
as clinically[26,27].
  The major findings of the present study are that AM 
exhibited marked hypoglycemic effects and improved 
serum lipid profile of STZ-diabetic animals. In addition, 
AM elicited better glycemic control evidenced by the HbA1c 
values of the treated diabetic rats when compared with 
untreated group. Furthermore, AM attenuated the increased 
毩-amylase and lactate dehydrogenase activities, and 
reduced the levels of serum urea in the diabetic rats.
  In this study, STZ was used to induce hyperglycemia in 
the rats. The use of STZ to induce diabetes mellitus in 
experimental animal models is widely accepted since STZ-
induced diabetes appears to resemble human hyperglycemic 
non-ketotic diabetes mellitus[28] and is often associated 
with kidney hypertrophy which may contribute to end 
stage renal damage, hepatotoxicity, oxidative stress and 
hypercholesterolemia[29,30]. It was noticed that AM exhibited 
hypoglycaemic activities in fasted STZ-diabetic rats up till 
4 h after extract administration. When the treatment period 
was extended to 3 weeks, AM further elicited significant 
hypoglycemic activities which were similar in action to 
the effects induced by glibenclamide. The significant 
hypoglycaemic effect of this extract may be indicative 
that AM exerts their effect by both direct and indirect 
mechanisms in the rats[31]. If the extract acted only as 
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indirect hypoglycaemic agents, no effect would be observed 
when they were administered to STZ-diabetic rats, since 
STZ administered at a dose of 35 mg/kg[10] should have 
caused severe destruction of 毬-cells of the pancreas[9]. The 
likely indirect mechanism suggests that AM probably act 
by stimulating the few surviving 毬-cells to release more 
insulin rather than by aiding the regeneration of necrotic
毬-cells of the pancreas. 
  In addition, the anti-diabetic activity of the extract was 
further confirmed with the normalization of HbA1c values 
in the diabetic rats treated with AM. HbA1c is an index of 
diabetic control that is used to assess the effectiveness of 
therapy in diabetes[32]. Furthermore, diabetic control was 
assessed by determining the activities of 毩-amylase of 
the diabetic rats[33]. In this study, the serum 毩-amylase 
activities of STZ diabetic rats were almost 2-fold higher than 
the normal rats. However, treatment with AM significantly 
attenuated the activities of this enzyme, which confirms 
better glycemic control by AM. 
  Still lingering for solutions are the secondary complications 
of diabetes such as nephropathy, cardiovascular disorders, 
hepatic damage, fatty liver, oxidative stress, etc. In this 
study, marked elevation of serum urea was observed in 
the STZ-diabetic rats, although the creatinine levels were 
insignificantly affected. This observation is consistent 
with the findings of Alderson et al[34] and Adisa et al[4] 
which reported elevated urea levels in serum of STZ-
diabetic rats. Serum creatinine and urea levels are sensitive 
and reliable biochemical indices for evaluation of renal 
function in animal model[35]. The increased serum urea 
levels indicate impairment to the kidney function such as 
acute glomerulonephritis, nephrosclerosis and even tubular 
necrosis[36]. Our data indicate that crude methanolic extract 
of African mistletoe at a dose of 100 mg/kg reduced the 
levels of serum urea in STZ-diabetic rats to near normalcy. 
This result indicates the possible protective effect of AM 
against diabetes-induced renal dysfunction in the animals. 
ALT and AST are reliable maker enzymes for liver function 
in animals. It is established that AST can be found in the 
liver, cardiac muscle, skeletal muscle, kidney, brain, 
pancreas, lungs, leukocytes and erythrocytes, whereas ALT 
is predominantly present in the liver[37]. The increased levels 
of AST and ALT indicate an increased permeability and 
damage and/or necrosis of hepatocytes[38]. The membrane 
bound enzymes like ALP and GGT are also released into 
bloodstream depending on the pathological phenomenon[39]. 
In our study, we found that the activities of AST, ALT, ALP 
and GGT in STZ-diabetic rats were insignificantly different 
from normal. This observation may be due to the short 
duration (3 weeks) of the study. It is therefore reasonable 
to suggest that to ascertain the effect of diabetes on the 
integrity of liver marker indices, the duration of study could 
be extended to 6-8 weeks. In addition to its hypoglycaemic 
effect, AM was able to improve lipid metabolites including 
total cholesterol, triglyceride, HDL- and LDL-cholesterol 
levels in the diabetic rats. Diabetes is associated with 
profound alterations in lipid and lipoprotein profiles[40]. 
Therefore, lowering of plasma or tissue lipid levels may lead 
to a decrease in the risk of micro- or macrovascular disease 
and related complications[41]. It can therefore be suggested 
that AM may improve lipid profiles directly or indirectly 
through reducing blood glucose in diabetic animals as 
observed in this study. 
  In conclusion, these results confirm antidiabetic and 
antihyperlipidemic effects of African mistletoe in STZ 
diabetic rats and further substantiated the claim of its use 
in folklore medicine as anti-diabetic agent. The beneficial 
effect of AM on lipid profile of diabetic rats suggests 
its possible amelioration of secondary complications of 
diabetes. Further detailed studies are required to establish 
the toxicity and active component of AM responsible for the 
observed effects.
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